Molecular Vision: Yin, Mol Vis 2009; 15:1252-1259. Table 1

Table 1. Numbers of mice in the different treatment groups with viral shedding and stromal disease.

Treatment group	Positive virus shedding^a (%)								Stromal disease^b (%)			Reactivation rate^c
Treatment group	D1	D2	D3	D4	D5	D6	D7	Total	D4	D7	Total
Saline treatment	0/76 (0)	12/76 (15.8)	29/76 (38.2)	46/76 (60.5)	22/70 (31.4)	10/70 (14.3)	2/70 (2.8)	58/76 (76.3)	37/76 (48.7)	47/70 (67.1)	61/76 (80.2)	53/76 (69.7)
Lornoxicam treatment	0/76 (0)	8/76 (10.5)	17/76* (22.4)	28/76* (36.8)	13/70 (18.6)	2/70* (2.8)	0/70 (0)	37/76* (48.7)	17/76* (22.4)	27/70* (38.6)	37/76* (48.7)	33/76* (43.4)

Eyes of mice with latent ocular HSV infection were UVB irradiated (day 0) and swabbed to detect recurrent viral shedding from days 0 to 7. The eyes were observed under a slit-lamp biomicroscope in a masked fashion. In the table, "^a" indicates the number of eyes shedding virus versus total number of eyes irradiated with UVB and "^b" indicates the incidence of stromal opacity in each group. "^c" indicates recurrent disease was defined as stromal opacification for more than two consecutive days and virus shedding in tears on any day from day 1 to day 7 post-UVB exposure with day 0 swabs serving as the control. D=days post UVB irradiation. An asterisk indicates that there was a significant difference when compared with the saline-treated group at the corresponding time points ( range p<0.001–0.080).